EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Pharmaceutical Cocrystals in Drug-Delivery Technologies: Advances from Rational Design to Therapeutic Applications

Marina Monserrat Marcos Valdez iD, Norma Rebeca Sperandeo iD, Maria Soledad Bueno, Claudia Garnero iD

Pharmaceutics · 20.01.2026 · 18 (1) · 128

DOI: 10.3390/pharmaceutics18010128 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 20.01.2026. Verfasst von Marina Monserrat Marcos Valdez und 3 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Ciencias Farmacéuticas, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Unidad de Investigación y Desarrollo en Tecno…. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 147 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pharmaceutical cocrystals are a well-established class of solid-state forms that can modulate the solubility, dissolution, stability, and bioavailability of active pharmaceutical ingredients without altering their molecular identity. Although traditional oral formulations have demonstrated translational potential, recent research has emphasized the importance of integrating cocrystals into emerging drug-delivery technologies. This review systematically analyzes recent advances in conventional and innovative cocrystal-based platforms, critically evaluating their therapeutic relevance. A comprehensive literature search was conducted, focusing on publications from the last decade, with emphasis on studies from 2020 to 2025, including peer-reviewed articles, patents, and regulatory documents. Evidence was organized into traditional oral, inhalable, intranasal, and transdermal formulations, followed by emerging platforms such as 3D printing, nano-cocrystals, and microneedles. Case studies and preclinical/clinical data were critically assessed to identify strengths, limitations, and future directions. Advancements in formulation science and novel delivery technologies are allowing pharmaceutical cocrystals to transition from laboratory innovations to clinical applications. Despite challenges in scalability, stability, and regulatory clarity, the application of cocrystals into emerging platforms highlights their potential as transformative tools in next-generation therapeutics.

Schlagwörter

Stichwörter der Autor:innen

advanced formulationsclinical translationcocrystalscrystal engineeringemerging drug-delivery technologies

Autor:innen und Institutionen

  • Departamento de Ciencias Farmacéuticas, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Unidad de Investigación y Desarrollo en Tecnología Farmacéutica (UNITEFA) CONICET-UNC, Córdoba X5000HUA, Argentina.

ORCID-Profile: Marina Monserrat Marcos Valdez, Norma Rebeca Sperandeo, Claudia Garnero

Zitieren

APA

Marcos Valdez, M. M., Sperandeo, N. R., Bueno, M. S., & Garnero, C. (2026). Pharmaceutical Cocrystals in Drug-Delivery Technologies: Advances from Rational Design to Therapeutic Applications. Pharmaceutics, 18(1), 128. https://doi.org/10.3390/pharmaceutics18010128

Vancouver

Marcos Valdez MM, Sperandeo NR, Bueno MS, Garnero C. Pharmaceutical Cocrystals in Drug-Delivery Technologies: Advances from Rational Design to Therapeutic Applications. Pharmaceutics. 2026;18(1):128. doi:10.3390/pharmaceutics18010128

BibTeX
@article{MarcosValdez2026,
  author = {Marcos Valdez, Marina Monserrat and Sperandeo, Norma Rebeca and Bueno, Maria Soledad and Garnero, Claudia},
  title = {Pharmaceutical Cocrystals in Drug-Delivery Technologies: Advances from Rational Design to Therapeutic Applications},
  journal = {Pharmaceutics},
  year = {2026},
  volume = {18},
  number = {1},
  pages = {128},
  doi = {10.3390/pharmaceutics18010128}
}
Kostenlos starten →